id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-275538-c44gmu22	Davis-Wurzler, Gina M.	Current Vaccination Strategies in Puppies and Kittens	2006-03-24		.txt	text/plain	10385	472	41	The current recommendation is to use the CAV-II MLV because it stimulates the immune system to protect against CAV-I and CAV-II without the associated adverse reaction caused by the type I vaccine [4, 14, 20] . There is a killed vaccine available; however, vaccination against this agent is typically not recommended, because most animals are not at risk to contract the parasite, the vaccine does not prevent infection (it may ameliorate clinical signs and decrease cyst shedding), and the disease is readily amenable to therapy (fenbendazole, albendazole, and metronidazole are off-label uses but commonly accepted as standard of care). Because the vaccine does not fully prevent infection and carries an association with adverse events that may be greater than the actual disease, routine vaccination of household pets with this product is generally not recommended.	./cache/cord-275538-c44gmu22.txt	./txt/cord-275538-c44gmu22.txt